Correction: Inventiva reports preliminary financial results for Full-Year 2022¹ Feb 14, 2023 05:00PM
Inventiva reports preliminary financial results for Full-Year 2022¹ Feb 14, 2023 04:00PM
Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and cedirogant in psoriasis Mar 7, 2022 04:26PM
Inventiva publie ses résultats annuels 2021 : Avancées majeures avec lanifibranor dans la NASH et cedirogant dans le psoriasis Mar 7, 2022 04:00PM
Inventiva announces participation at several conferences in March 2022 Mar 1, 2022 04:00PM


Feb 14, 2022 04:00PM Inventiva reports cash position and revenues for Full-Year 2021